Salt substitutes effective in reducing hypertension in elderly people
HQ Team February 13, 2024: Adding to the long line of evidence that reducing salt intake affects blood pressure is the latest study.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team February 13, 2024: Adding to the long line of evidence that reducing salt intake affects blood pressure is the latest study.
HQ Team February 13, 2024: Gilead Sciences is buying CymaBay Therapeutics for $4.3 billion, to access its portfolio of drugs for liver and.
HQ Team February 12, 2024: People with depression may have higher body temperatures and lowering the heat is likely to be beneficial to.
HQ Team February 12, 2024: Scientists have discovered five known cases of possible medically acquired Alzheimer’s disease after the patients have undergone previous.
HQ Team February 9, 2024: The coronavirus may have lost its virulence with time but its long-term effects are still being revealed among.
HQ Team February 8, 2024: Australian scientists may have found a drug to treat triple-negative breast cancer without any toxic effects, according to.
HQ Team February 8, 2024: Gilead Sciences, Inc., announced it has discontinued trials on a drug to treat blood cancer after the US.
HQ Team February 6, 2024: A projection from the Global Cancer Observatory suggests that new cancer cases worldwide are set to surge by.
A study conducted by researchers from Harvard University has revealed a concerning trend within the pharmaceutical industry— the widespread adoption of intricate patent.
HQ Team February 6, 2024: Novartis AG is set to buy a German-based biotechnology company, MorphoSys AG, for $2.9 billion, giving the Swiss.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)